ArticleThe oncologist2015

Genomic classifier ColoPrint predicts recurrence in stage II colorectal cancer patients more accurately than clinical factors.

Scott Kopetz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.